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Background: Endolysins produced by bacteriophages lyse bacteria, and are thus considered a novel type of
antimicrobial agent. Several endolysins from Bacillus phages or prophages have previously been characterized and
used to target Bacillus strains that cause disease in animals and humans. B. thuringiensis phage BtCS33 is a
Siphoviridae family phage and its genome has been sequenced and analyzed. In the BtCS33 genome, orf18 was
found to encode an endolysin protein (PlyBt33).
Results: Bioinformatic analyses showed that endolysin PlyBt33 was composed of two functional domains, the
N-terminal catalytic domain and the C-terminal cell wall binding domain. In this study, the entire endolysin PlyBt33,
and both the N- and C-termini,were expressed in Escherichia coli and then purified. The lytic activities of PlyBt33
and its N-terminus were tested on bacteria. Both regions exhibited lytic activity, although PlyBt33 showed a higher
lytic activity than the N-terminus. PlyBt33 exhibited activity against all Bacillus strains tested from five different
species, but was not active against Gram-negative bacteria. Optimal conditions for PlyBt33 reactivity were pH 9.0
and 50°C. PlyBt33 showed high thermostability, with 40% of initial activity remaining following 1 h of treatment
at 60°C. The C-terminus of PlyBt33 bound to B. thuringiensis strain HD-73 and Bacillus subtilis strain 168. This
cell wall binding domain might be novel, as its amino acid sequence showed little similarity to previously
reported endolysins.
Conclusions: PlyBt33 showed potential as a novel antimicrobial agent at a relatively high temperature and had
a broad lytic spectrum within the Bacillus genus. The C-terminus of PlyBt33 might be a novel kind of cell wall
binding domain.
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Endolysins are enzymes produced by bacteriophages
(phages) at the end of their life cycles to lyse the cell
walls of host cells and release mature progeny phage
particles [1,2]. Most endolysins require a second phage
protein, holin, to create pores in the cytomembrane and
enable them to pass through to reach their substrate, a
cell wall peptidoglycan [3,4]. Because of their potential
as novel antibacterial agents, the characteristics of sev-
eral endolysins have previously been studied [5-10].* Correspondence: mygao@wh.iov.cn
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reproduction in any medium, provided the orEndolysins of phages isolated from Gram-positive bac-
teria typically contain two functional domains, the
N-terminal catalytic domain and the C-terminal cell wall
binding domain [1]. The catalytic domain belongs to one
of the four families of peptidoglycan hydrolases, which
are classified according to catalytic site-specificity:
N-acetylglucosaminidases, N-acetylmuramidases (lyso-
zymes), N-acetylmuramoyl-L-alanine amidases, and
endopeptidases [1,11]. By contrast, the cell wall binding
domain is divergent and can distinguish discrete cell wall
epitopes. Usually, one cell wall binding domain
determines the endolysin strain specificity [11,12]; how-
ever, there are sometimes more than one [7,13,14] or
even no cell wall binding domains [15,16]. The endolysin
C-terminus nevertheless sometimes appears to bed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that the enzymatic activity is abolished after removal of
the C-terminus [17,18].
Bacillus thuringiensis belongs to the Bacillus cereus
group, which includes two very closely related species:
B. cereus and Bacillus anthracis [19]. B. thuringiensis is
an insect pathogen that forms an insecticidal crystal pro-
tein during sporulation [20]. B. anthracis is the anthrax
pathogen, while B. cereus is a food contaminant [19]. Be-
cause of the multidrug resistance of B. anthracis [21,22],
several of its phage or prophage endolysins have been
expressed, purified, and characterized. There have alsoFigure 1 Amino acid sequence alignment and structural composition
sequences of PlyBt33 with other bacteriophage endolysins. PlyPH, PlyBa04,
PlyG was the endolysin from B. anthracis phage Gamma [17,28]; Ply21 was
cell wall binding activity of PlyG to B. anthracis [30] and the corresponding
representation of PlyBt33 and other Bacillus. sp. endolysins. Amidase_2 and
Amidase02_C and SH3_5 represented the cell wall binding region of each
acid residue positions.been some attempts to use these endolysins to cure the
disease caused by B. anthracis [8,9,11,17,18,23]. Practical
applications of endolysins were enabled by studies on
functional domain composition, optimal reaction condi-
tions, and species- or strain-specificity. For example,
combining the catalytic domain of one endolysin with
the cell wall binding domain of another changed the
specificity or activity [24].
Until now, only two bacterial cell wall hydrolases from
B. thuringiensis phage GIL01 have been reported [25],
and little is known about their functional domain com-
position. The lytic activity of one of these hydrolases wasof the studied Bacillus endolysins. (a) Alignment of the amino acid
and PlyL were the putative B. anthracis prophage endolysins [9,16,22];
the endolysin from B. cereus phage TP21[9,29]. Residues critical for the
residues in the other endolysins were boxed in red. (b) Schematic
GH-25 represented the catalytic region of each endolysin;
endolysin. The numbers above the rectangles corresponded to amino
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exhibited a broader cleavage spectrum in lysing two
other Gram-positive species, B. subtilis and Micrococcus
lysodeikticus.
Phage BtCS33 is a Siphoviridae family member that
was isolated from B. thuringiensis kurstaki strain CS-33
[26]. The BtCS33 genome has been sequenced and a po-
tential endolysin gene, orf18, was identified using bio-
informatics. The gene product was named PlyBt33. In
this study, we analyzed the functional domain compos-
ition of PlyBt33 using bioinformatics, and then demon-
strated its biological activity after separately expressing
the catalytic and cell wall binding domains in Escherichia
coli. PlyBt33 showed a broad lytic spectrum against the
tested Bacillus strains. Additionally, its cell wall binding
domain exhibited low amino acid sequence similarity to
previously reported domains.
Results
Identification and domain composition of endolysin from
phage BtCS33
Position-specific iterated BLAST (PSI-BLAST) analysis of
the phage BtCS33 genome identified orf18 as the gene
encoding the endolysin PlyBt33. Amino acid sequence
alignment of PlyBt33 with several endolysins from Bacillus
phages or prophages (Figure 1a) revealed high similarity to
PlyPH [9] and PlyBa04 [23] (about 67% and 71%, respect-
ively), but low similarity to PlyG [18], PlyL [17], and Ply21
[27] (less than 15%).
Pfam and CDD analysis showed that PlyBt33 was
composed of two functional domains (Figure 1b), the N-
terminal catalytic domain (amino acid residues 5–186)
and the C-terminal cell wall binding domain (amino acid
residues 224–269). Figure 1b showed the Pfam analysisFigure 2 Schematic diagram and SDS-PAGE analysis of expressed Ply
expressed PlyBt33 (full length), PlyBt33-N (N-terminal), and PlyBt33-IC (IC-te
amino acid residues. (b) SDS-PAGE analysis of expressed and purified PlyBt
lane 1, Ni-NTA column-purified PlyBt33 from E. coli supernatant following u
supernatant following ultrasonication; lane 3, Ni-NTA column-purified PlyBt
PlyBt33-N, and PlyBt33-IC bands appeared at 33 kDa, 24 kDa, and 11 kDa, rof four endolysins from Bacillus phages, and indicated
that the N-terminus of PlyBt33 was a GH25 family hydro-
lase domain, while the C-terminus was an amidase02_C
domain. PlyBt33 exhibited the same domain composition
as PlyPH, but differed from PlyG and Ply21. According to
homology-based endolysin classification [1], PlyBt33 is a
putative member of the N-acetylmuramoyl-L-alanine
amidases.
Expression and purification of endolysin
To determine the function of the entire PlyBt33 protein,
the N-terminal region (PlyBt33-N, amino acids 1–186),
and the C-terminus combined with the internal region
(PlyBt33-IC, amino acids 187–272) (Figure 2a), we con-
structed three recombinant strains and induced protein
expression with isopropyl-β-D-thio-galactoside (IPTG).
Sodium dodecyl sulfate polyacrylamide gel electrophor-
esis (SDS-PAGE) analysis showed that the three
observed molecular weights coincided with their theor-
etical weights of 31 kDa, 24 kDa, and 11 kDa, respect-
ively. SDS-PAGE analysis also showed that the purity of
each protein following Ni-NTA purification exceeded
90% (Figure 2b).
Lytic activity of PlyBt33
The relationship between different concentrations of
PlyBt33 and their corresponding lytic activities was
tested. Figure 3 showed a linear relationship from 0.5 μM
to 4 μM. For further assays, we used a final concentration
of 2 μM as this concentration lies within the linear activ-
ity range of PlyBt33. The lytic activities of PlyBt33-N and
PlyBt33-IC were investigated to determine the active
region of PlyBt33. The results revealed that PlyBt33-N
but not PlyBt33-IC lysed B. thuringiensis strain HD-73Bt33 and its functional domains. (a) Schematic diagram of
rminal) proteins. The numbers above the rectangle correspond to
33, PlyBt33-N, and PlyBt33-IC proteins. Marker, molecular mass marker;
ltrasonication; lane 2, Ni-NTA column-purified PlyBt33-N from E. coli
33-IC from E. coli supernatant following ultrasonication. PlyBt33,
espectively.
Figure 3 Relationship between PlyBt33 concentration and lytic
activity. Lytic activities of PlyBt33 on viable cells of B. thuringiensis
strain HD-73 with different PlyBt33 concentrations were tested. The
initial OD600 of the strain suspension was 0.8 and the test was
carried out at 37°C in 20 mM Tris-HCl (pH 8.0). The decrease of
OD600 (%) = (1− the absorbance of the bacterial suspension at the
end of each treatment / the absorbance at the beginning of each
treatment) × 100%. The assay was carried out in triplicate and the
mean values were used.
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PlyBt33 was the N-terminus, although the lytic activ-
ity of PlyBt33-N was relatively low when compared
with PlyBt33 (Figure 4e). To detect the lytic spectrum
of PlyBt33, the lytic activity of purified PlyBt33 was
tested against B. thuringiensis strains HD-73, HD-1,
four B. thuringiensis isolates, B. subtilis, B. pumilus,
B cereus, B. anthracis, and the Gram-negative strains
P. aeruginosa, Y. pseudotuberculosis, and E. coli.Figure 4 Lytic activity assay of PlyBt33, PlyBt33-N, and PlyBt33-IC. (a)
suspended in 20 mM Tris-HCl (pH8.0) of PlyBt33 (a), PlyBt33-N (b), and PlyB
placed onto the bacterial lawn of B. thuringiensis HD-73. (e) Lysis of viable
mM Tris-HCl with a final protein concentration of 2 μM at 37°C. Crude extr
thuringiensis strain HD-73.PlyBt33 lysed all Bacillus strains tested, but not the
Gram-negative strains. The lytic activity against B.
thuringiensis was low, but was much higher against B.
subtilis and B. pumilus (Figure 5a), which corresponded
with previous reports [17,31]. Furthermore, PlyBt33 lysed
B. cereus and B. anthracis with higher lytic activity.
The effects of pH and temperature on PlyBt33 lytic activ-
ity were investigated. Lytic activity against the tested strains
was observed in the pH range of 7.0–12.0, with an optimal
pH of 9.0 (Figure 5b). The optimum reaction temperature
was 50°C (Figure 5c), and lytic activity gradually decreased
as temperature increased from 30–60°C (Figure 5d). Fol-
lowing treatments at 40°C and 60°C for 1 h, lytic activity
was reduced by 40% and 60%, respectively.
Cell wall binding activity of PlyBt33-IC
According to previous reports, the C-termini of sev-
eral characterized Gram-positive endolysins comprised
one or several SH3 family cell wall binding domains
[11,14,30]. Pfam analysis of PlyBt33 showed that the
PlyBt33 C-terminus consisted of an Amidase02_C do-
main, which was present in several endolysins [9,18].
We aligned the PlyBt33 C-terminus with other char-
acterized cell wall binding domains from Bacillus
phage or prophage endolysins, and observed limited
similarity. However, the highest similarity was found
with the C-termini of PlyG, PlyL, PlyBa04, and PlyPH
(Figure 1). Kikkawa et al. previously reported that
amino acid residues L190 and Q199 of endolysin
PlyG were critical for the cell wall binding activity of
PlyG to B. anthracis [32]. Figure 1 showed that
PlyBt33 and PlyG shared identical L190 residues but
differred at amino acid 199., (b), (c), and (d). Filter papers were soaked in the crude extract
t33-IC (c) from E. coli M15, and E. coli M15 containing pQE-30 (d), and
cells using purified PlyBt33 and PlyBt33-N. Tests were performed in 20
act of E. coli M15 containing pQE-30 was used as a control to treat B.
Figure 5 Characterization of the endolysin PlyBt33. (a) Lysis of viable cells from five different Bacillus species and one E. coli strain by PlyBt33.
Tests were carried out with a final protein concentration of 2 μM at 37°C in 20 mM Tris-HCl (pH 8.0). The initial OD600 of each strain suspension
was 0.8. Crude extract of E. coli M15 containing pQE-30 was used as a control to treat B. thuringiensis strain HD-73. (b) pH-dependent activity of
PlyBt33. Tests were carried out with a final protein concentration of 2 μM at 37°C in 20 mM Tris at varying pH levels. (c) Temperature-dependent
activity of PlyBt33. Tests were carried out with a final protein concentration of 2 μM in 20 mM Tris-HCl (pH 8.0) at varying temperatures. (d)
Temperature stability of PlyBt33. Proteins were first treated at different temperatures for 1 h and then the tests were carried out with a final
protein concentration of 2 μM at 37°C in 20 mM Tris-HCl (pH 8.0). In (b), (c), and (d), decrease of OD600 (%) = (1− the absorbance of the bacterial
suspension at the end of each treatment / the absorbance at the beginning of each treatment) × 100%.
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labeled with fluorescein isothiocyanate (FITC). After
mixing FITC-PlyBt33-IC with the bacterial suspension
for 5 min, the cells were visualized under a fluorescence
microscope, and binding between FITC-PlyBt33-IC and
the surface of B. thuringiensis HD-73 was apparent
(Figure 6a). The binding ability assay was also repeated with
a higher FITC-PlyBt33-IC concentration (0.05 mg/ml).
At this concentration, homogenous binding of FITC-
PlyBt33-IC to the cell surface was observed (data not
shown), in contrast to the random binding pattern seen at
the lower concentration. FITC-labeled bovine serum albu-
min (BSA) showed no binding to HD-73 (Figure 6b), and
the HD-73 cell suspensions used as a control showed no
fluorescence (Figure 6c). FITC-PlyBt33-IC also bound to
B. subtilis 168, while no binding was detected in E. coli
(data not shown). The binding activity of PlyBt33-IC was
consistent with its lytic specificity.Discussion
In the present work, we expressed and determined the ac-
tivity of endolysin PlyBt33 from B. thuringiensis phage
BtCS33. The endolysin was found to be a putative
N-acetylmuramoyl-L-alanine amidase, and was composed
of an N-terminal catalytic domain and a C-terminal
cell wall binding domain. PlyBt33 maintained 40% of its
lytic activity against bacterial cells following treatment at
60°C for 1 h.
Though PlyBt33 exhibited a high sequence similarity
(67%) to endolysin PlyPH, their characteristics were quite
different. PlyPH was a B. anthracis putative prophage
origin endolysin that could lyse B. anthracis and B. cereus,
and had a broad optimal pH range (pH 4.0–10.5) [9].
By contrast, PlyBt33 exhibited lytic activity between pH
7.0–12.0, with an optimal pH of 9.0. The differences be-
tween the amino acid sequences of these two endoly-
sins may cause differences in pI (putative pI 8.51 for
Figure 6 Binding ability of FITC-PlyBt33-IC to viable cells of B. thuringiensis HD-73, as observed by phase contrast (upper panels) and
fluorescence (lower panels) microscopy. (a) Binding of FITC-PlyBt33-IC to the entire surface of HD-73; (b) No binding of FITC-BSA to HD-73
was observed; (c) HD-73 cell suspension with no protein was used as a control.
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charges. Low et al. [23] reported that the net charge of
endolysin PlyBa04 influenced its lytic activity and speci-
ficity, which might explain the different pH ranges of
these two endolysins. Moreover, the lytic spectrums of
PlyBt33 and PlyPH were also different. PlyBt33 could
hydrolyze all tested Bacillus strains from five different
species, while PlyPH could only lyse B. anthracis and
B. cereus. Alignments of the putative cell wall binding
domains of PlyBt33 and PlyPH revealed a low similarity
(about 20%). According to previous reports, cell wall
binding was essential in the host range determination
of the endolysin [12,32,33], and this might be the cause
of the different target-specificities of PlyBt33 and
PlyPH. The same phenomenon was observed in endoly-
sin PlyG (lytic specificity for B. anthracis and B. cereus)
[18], which showed high similarity to PlyPH and low
similarity to PlyBt33 at the putative cell wall binding re-
gion. Contrarily, B. anthracis endolysin PlyL showed
low similarity to PlyBt33 at the putative cell wall bind-
ing region, but exhibited a relatively broad lytic
spectrum. Both endolysins could lyse strains of B.
anthracis, B. cereus, and B. subtilis [17]. We speculated
that this was either because the different cell wall bind-
ing domains recognized the same cell wall epitope, or
that there were various cell wall epitopes available for
binding. Because of the low similarity of the PlyBt33
cell wall binding domain with others, we inferred that it
might be a novel type of cell wall binding domain.
We observed random binding of the FITC labeled cell
wall binding proteins with ligands on the cell surface
(Figure 6a). The concentration used of the FITC labeledcell wall binding proteins (0.0125 mg/ml) was low,
and as such only parts of the ligands were bound by
the FITC labeled cell wall binding proteins. When
a higher concentration (0.05mg/ml) was used, the FITC
labeled cell wall binding proteins bound uniformly to
the cell surface (data not shown). These results sug-
gested a homogenous distribution of ligands on the cell
surface, which agrees with the findings of previous
reports [12].
In previous reports, the lytic activity of PlyL
increased after removing the C-terminal region [17],
while the lytic activity of PlyG was reduced [18].
Though the similarity between the N-terminal regions
of PlyG and PlyL was high, they each exhibited dis-
tinct features. The similarity of PlyBt33 to PlyG and
PlyL was low; therefore we decided to investigate the
influence of the C-terminus on the lytic activity of
PlyBt33. In this study, when the C-terminus of PlyBt33
was removed, the lytic activity was reduced. We specu-
lated that this was due to the C-terminus assisting in
the binding of PlyBt33 to the catalytic epitope on the
cell wall of target bacteria, which benefits the catalysis
of PlyBt33.
PlyBt33 had a relatively high thermostability, which,
combined with its high lytic activity against B. cereus
(a source of toxins in the food industry) [34,35],
suggested that it had the potential to be an extremely
useful antimicrobial agent in food production pro-
cesses involving heat treatment [36]. PlyBt33 also
exhibited a high lytic activity against B. anthracis,
which indicated that it could be used in the treat-
ment of anthrax [19].
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The endolysin PlyBt33 was composed of two functional
domains, the N-terminal catalytic domain and the
C-terminal cell wall binding domain. The C-terminus of
PlyBt33 might be a novel kind of cell wall binding do-
main. PlyBt33 lysed all tested Bacillus strains from five
different species. Optimal conditions for PlyBt33 were
pH 9.0 and 50°C, and PlyBt33 was also found to be rela-
tively thermostable. These characteristics indicated that
PlyBt33 might be an extremely useful antimicrobial
agent in food production processes that involve heat
treatment, and in the treatment of anthrax.Methods
Bacterial strains and cultures
E. coli expression of the endolysin gene, respectively.
B. thuringiensis strain HD-73 is the standard strain of
B. thuringiensis subsp. kurstaki [37], while B. subtilis
strain 168, obtained from Dr. Yuan Zhiming (Wuhan
Institute of Virology, Chinese Academy of Sciences,
Wuhan, China), is the most widely used model strain
of B. subtilis [38]. B. anthracis CMCC63605 with the
pXO1 plasmid eliminated was provided by Dr. Yuan
Zhiming (Wuhan Institute of Virology, Chinese Acad-
emy of Sciences, Wuhan, China). B. thuringiensis strain
CS-33 (CCTCC No. M202025) and phage BtCS33
(CGMCC7.61) were isolated by our laboratory. Other
B. thuringiensis, B. cereus, and B. pumilus strains used in
this study were collected and identified by our laboratory.
Pseudomonas aeruginosa PAO1 (ATCC47085) and
Yersinia pseudotuberculosis NaI (provided by Dr. Wang
Yao, Wuhan Institute of Virology, Chinese Academy of
Sciences, Wuhan, China) were used to test the lytic
spectrum of the endolysin. All strains were grown in LB
medium.Bioinformatic analysis of the putative endolysin gene of
phage BtCS33
Open reading frames (ORFs) of the phage BtCS33 genome
(GenBank: JN191664) were predicted using FGENE SV
software (http://linux1.softberry.com/berry.phtml?topic=-
virus&group=programs&subgroup=gfindv) and by visual
inspection. The non-redundant protein database was
searched using BLASTP [39] with the amino acid se-
quences of endolysins from BtCS33 and PlyBt33 as the
query. ORF18 was predicted to encode the endolysin from
BtCS33. Amino acid sequences of PlyBt33 and several
known endolysins were aligned using ClustalW2 [40] and
manually adjusted. Functional domains were searched
against the Pfam database (http://pfam.sanger.ac.uk/
search) [41] and the CDD database (http://www.ncbi.nlm.
nih.gov/cdd) [42].Plasmid construction and transformation
DNA manipulations were performed according to stand-
ard protocols [43]. Phage BtCS33 genomic DNA was
extracted as previously described [44] and used as a tem-
plate to amplify the entire endolysin gene (ORF18, also
known as plyBt33 and expressed as protein PlyBt33), the
N-terminal region gene (plyBt33-N, expressed as
PlyBt33-N), and the internal and C-terminal region gene
(plyBt33-IC, expressed as PlyBt33-IC). Primers and cor-
responding PCR products are listed in Table 1. Amplifi-
cations were performed in a Veriti 96-Well Thermal
Cycler (Applied Biosystems, Foster City, CA) with an
annealing temperature of 55°C. PCR products were puri-
fied using a DNA extraction kit (Omega Bio-Tek,
Norcross, GA) and inserted into the BamHI/SalI site of
pQE-30 (Qiagen, Germany), which contains a His-tag
for protein purification. Three recombinant plasmids
were transformed into E. coli TG1, and three into E. coli
M15. Positive transformants were selected and verified
by DNA sequencing using a PRISM 3730 DNA analyzer
(Applied Biosystems).
Protein expression and purification
Three transformants containing genes plyBt33, plyBt33-
N, and plyBt33-IC were cultured in LB broth containing
100 μg/ml ampicillin at 37°C with moderate rotation
until cultures reached OD600 = 0.4. Cultures were then
induced by the addition of 1 mM IPTG at 16°C for 4 h.
Cells were collected by centrifugation at 10,000 × g for
10 min and resuspended in 20 mM Tris-Cl (pH 7.5).
Following ultrasonication, debris was removed by centri-
fugation and the suspensions were harvested. Following
filtration, proteins in the suspensions were purified using
a Ni-nitrilotriacetic acid (NTA; Qiagen, German) col-
umn according to the manufacturer’s instructions. Pro-
teins PlyBt33 and PlyBt33-N were analyzed using 10%
SDS-PAGE, while protein PlyBt33-IC was analyzed using
15% SDS-PAGE. Protein concentrations were calculated
using the Bradford method [45]. Purified proteins were
dialyzed against 20 mM Tris-HCl (pH 8.0) and stored
at −20°C until required.
Lytic activity assay
Crude protein extracts and purified proteins were
assayed for lytic activity as described previously [7,17].
B. thuringiensis strains HD-73 and HD-1, four B. thurin-
giensis isolates, B. subtilis, B. pumilus, B cereus, B.
anthracis, and the Gram-negative strains P. aeruginosa,
Y. pseudotuberculosis, and E. coli were used as indicator
strains. Strains were grown to mid-exponential phase in
LB broth, and then cells were harvested by centrifuga-
tion and resuspended in 20 mM Tris-HCl buffer
(pH 8.0). The Gram-negative strain cells were treated
with 1 mM EDTA in PBS to permeabilize the outer
Table 1 Oligonucleotide primers pairs used in this study




plyBt33-F/ BamHI GAGGATCC*ATGGGTTACACTGTAGATATTTC plyBt33
(816bp)
PlyBt33/33kDa
(amino acid residues 1–272)
plyBt33-R/ SalI GACGTCGACTTCTTTTGTATAAAAGTATTTAA
plyBt33-F/ BamHI GAGGATCCATGGGTTACACTGTAGATATTTC plyBt33-N
(558bp)
PlyBt33-N/24kDa





(amino acid residues 187–272)
plyBt33-R/ SalI GACGTCGACTTCTTTTGTATAAAAGTATTTAA
*The characters underline represents the restriction enzymes digest sites.
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PlyBt33. For rapid screening of the lytic spectrum, the
indicator strains were plated onto LB plates and crude
lysate of expressed proteins was added to filter paper
that was placed on the bacterial lawn. Plates were incu-
bated at 30°C overnight. Additionally, purified proteins
were added at a ratio of 1:9 to cell suspensions (initial
OD600 = 0.8) and the absorbance at OD600was moni-
tored at 37°C for 1 h with a multimode reader (Bio-Tek
Synergy HT, Winooski, VT). The crude extract of E. coli
M15 containing plasmid pQE-30 was used as a control.
The optimal reaction pH of the endolysin was
examined by adding dialyzed endolysins to cells of B.
thuringiensis strain HD-73 resuspended in a series of
buffers (20 mM Tris) at various pH levels (pH 3.0, 4.0,
5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, and 12.0), and the OD600
was monitored as described above. The optimal reaction
temperature of the endolysin was tested in 20 mM
Tris-HCl (pH 8.0) at temperatures of 10–80°C in 10°C
increments, and the OD600 was again monitored. To
analyze the endolysin thermostability, endolysins in 20
mM Tris-HCl (pH 8.0) were first treated at different tem-
peratures (4°C, 30°C, 40°C, 50°C, and 60°C) for 1 h and
the lytic activity was tested as described above. All
experiments were carried out in triplicate.
Labeling and binding activity assay of PlyBt33-IC
To test binding activity, purified PlyBt33-IC was labeled
with FITC (Sigma-Aldrich, Saint Louis, MO) according
to the manufacturer’s instructions. Following purifica-
tion, PlyBt33-IC protein was dialyzed four times against
FITC reaction buffer (7.56 g NaHCO3, 1.06 g Na2CO3,
7.36 g NaCl, with MilliQ water added to 1 l and the pH
adjusted to 9.0). FITC was dissolved in dimethyl sulfox-
ide to a concentration of 1 mg/ml and added into the
PlyBt33-IC suspension at a ratio of 150 μg FITC to 1 mg
PlyBt33-IC. Following 8 h incubation at 4°C in the dark,
the reaction was stopped with NH4Cl at a final concen-
tration of 50 mM for 2 h at 4°C in the dark. The labeled
protein was dialyzed against PBS (8 g NaCl, 0.2 g KCl,
3.49 g Na2HPO4.12H2O, 0.24 g KH2PO4, with MilliQ
water added to 1 l and the pH adjusted to 7.4) severaltimes until the dialysis liquid was colorless, and stored
at −20°C until required. BSA was also labeled as above
and used as a control. FITC-labeled proteins were
named FITC-PlyBt33-IC and FITC-BSA.
The specific binding activity of PlyBt33-IC to the
cell wall was assayed as described previously with
some modifications [12,46]. B. thuringiensis strain HD-
73 was grown to mid-exponential phase in LB
broth (OD600 = 0.8), and the cells were harvested by cen-
trifugation (10,000 × g for 1 min) and resuspended in a
one-tenth volume of PBS-T (pH 7.4, 0.01% Tween 20).
FITC-labeled PlyBt33-IC was added to a 100 μl cell sus-
pension to a final concentration of 0.0125 mg/ml and
incubated at 30°C for 5 min. For fluorescence microscopy
observation, the cells were harvested by centrifugation
and washed twice with 500 μl PBS-T buffer. The pellet
was then resuspended in 50 μl PBS-T. FITC-labeled BSA
was used as a control. All cells were observed using an
Olympus BX51 microscope.
Competing interests
The authors have no competing interests to declare.
Authors’ contributions
YHY and QP conducted the protein analysis. YHY performed the
bioinformatics analyses. MYG supervised the work. MYG and YHY designed
the study and wrote the manuscript. All authors reviewed and approved the
final version of the manuscript.
Acknowledgments
This study was supported by the National Natural Science Foundation of
China (No.31170123), the National Project (2009ZX08009-056B), and the
projects of the Chinese Academy of Sciences (KSCX2-EW-G-16).
Received: 13 July 2012 Accepted: 10 December 2012
Published: 19 December 2012
References
1. Hermoso JA, Garcia JL, Garcia P: Taking aim on bacterial pathogens: from
phage therapy to enzybiotics. Curr Opin Microbiol 2007, 10(5):461–472.
2. Loessner MJ: Bacteriophage endolysins - current state of research and
applications. Curr Opin Microbiol 2005, 8(4):480–487.
3. White R, Chiba S, Pang T, Dewey JS, Savva CG, Holzenburg A, Pogliano K,
Young R: Holin triggering in real time. Proc Natl Acad Sci USA 2011,
108(2):798–803.
4. Loessner MJ, Wendlinger G, Scherer S: Heterogeneous Endolysins in
Listeria-Monocytogenes Bacteriophages - a New Class of Enzymes and
Evidence for Conserved Holin Genes within the Siphoviral Lysis
Cassettes. Mol Microbiol 1995, 16(6):1231–1241.
Yuan et al. BMC Microbiology 2012, 12:297 Page 9 of 9
http://www.biomedcentral.com/1471-2180/12/2975. Fenton M, Ross RP, McAuliffe O, O'Mahony J, Coffey A: Characterization of
the staphylococcal bacteriophage lysin CHAP(K). J Appl Microbiol 2011,
111(4):1025–1035.
6. Gupta R, Prasad Y: P-27/HP Endolysin as Antibacterial Agent for Antibiotic
Resistant Staphylococcus aureus of Human Infections. Curr Microbiol 2011,
63(1):39–45.
7. Nariya H, Miyata S, Tamai E, Sekiya H, Maki J, Okabe A: Identification and
characterization of a putative endolysin encoded by episomal phage
phiSM101 of Clostridium perfringens. Appl Microbiol Biot 2011,
90(6):1973–1979.
8. Schuch R, Nelson D, Fischetti VA: A bacteriolytic agent that detects and
kills Bacillus anthracis. Nature 2002, 418(6900):884–889.
9. Yoong P, Schuch R, Nelson D, Fischetti VA: PlyPH, a bacteriolytic enzyme
with a broad pH range of activity and lytic action against Bacillus
anthracis. J Bacteriol 2006, 188(7):2711–2714.
10. Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG,
Dong S, Donovan DM: Endolysins as antimicrobials. Adv Virus Res 2012,
83:299–365.
11. Porter CJ, Schuch R, Pelzek AJ, Buckle AM, McGowan S, Wilce MCJ, Rossjohn
J, Russell R, Nelson D, Fischetti VA: The 1.6 A crystal structure of the
catalytic domain of PlyB, a bacteriophage lysin active against Bacillus
anthracis. J Mol Biol 2007, 366(2):540–550.
12. Loessner MJ, Kramer K, Ebel F, Scherer S: C-terminal domains of Listeria
monocytogenes bacteriophage murein hydrolases determine specific
recognition and high-affinity binding to bacterial cell wall carbohydrates.
Mol Microbiol 2002, 44(2):335–349.
13. Nelson D, Schuch R, Chahales P, Zhu SW, Fischetti VA: PlyC: A multimeric
bacteriophage lysin. Proc Natl Acad Sci USA 2006, 103(28):10765–10770.
14. Schmitz JE, Ossiprandi MC, Rumah KR, Fischetti VA: Lytic enzyme discovery
through multigenomic sequence analysis in Clostridium perfringens.
Appl Microbiol Biot 2011, 89(6):1783–1795.
15. Matthews BHM, Matthews BW: Extension to 2268 atoms of direct
methods in the ab initio determination of the unknown structure of
bacteriophage P22 lysozyme. Acta Crystallogr D 2006, 62:165–176.
16. Xu M, Arulandu A, Struck DK, Swanson S, Sacchettini JC, Young R: Disulfide
isomerization after membrane release of its SAR domain activates P1
lysozyme. Science 2005, 307(5706):113–117.
17. Low LY, Yang C, Perego M, Osterman A, Liddington RC: Structure and lytic
activity of a Bacillus anthracis prophage endolysin. J Biol Chem 2005,
280(42):35433–35439.
18. Kikkawa HS, Ueda T, Suzuki S, Yasuda J: Characterization of the catalytic
activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis.
FEMS Microbiol Lett 2008, 286(2):236–240.
19. Vilas-Boas GT, Peruca APS, Arantes OMN: Biology and taxonomy of Bacillus
cereus, Bacillus anthracis, and Bacillus thuringiensis. Can J Microbiol 2007,
53(6):673–687.
20. Schnepf E, Crickmore N, Van Rie J, Lereclus D, Baum J, Feitelson J,
Zeigler DR, Dean DH: Bacillus thuringiensis and its pesticidal crystal
proteins. Microbiol Mol Biol R 1998, 62(3):775-+.
21. Serizawa M, Sekizuka T, Okutani A, Banno S, Sata T, Inoue S, Kuroda M:
Genomewide Screening for Novel Genetic Variations Associated with
Ciprofloxacin Resistance in Bacillus anthracis. Antimicrob Agents Ch 2010,
54(7):2787–2792.
22. Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ, Rubinstein E:
Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob
Chemoth 2004, 54(2):424–428.
23. Low LY, Yang C, Perego M, Osterman A, Liddington R: Role of Net Charge
on Catalytic Domain and Influence of Cell Wall Binding Domain on
Bactericidal Activity, Specificity, and Host Range of Phage Lysins. J Biol
Chem 2011, 286(39):34391–34403.
24. Lopez R, Garcia E, Garcia P, Garcia JL: The pneumococcal cell wall
degrading enzymes: A modular design to create new lysins? Microbial
Drug Resistance-Mechanisms Epidemiology and Disease 1997, 3(2):199–211.
25. Verheust C, Fornelos N, Mahillon J: The Bacillus thuringiensis phage GIL01
encodes two enzymes with peptidoglycan hydrolase activity.
FEMS Microbiol Lett 2004, 237(2):289–295.
26. Yuan YH, Gao MY, Wu DD, Liu PM, Wu Y: Genome characteristics of a
novel phage from Bacillus thuringiensis showing high similarity with
phage from Bacillus cereus. PLoS One 2012, 7(5):e37557.
doi:10.1371/journal.pone.00.7557.27. Loessner MJ, Maier SK, DaubekPuza H, Wendlinger G, Scherer S: Three
Bacillus cereus bacteriophage endolysins are unrelated but reveal high
homology to cell wall hydrolases from different bacilli. J Bacteriol 1997,
179(9):2845–2851.
28. Fouts DE, Rasko DA, Cer RZ, Jiang LX, Fedorova NB, Shvartsbeyn A,
Vamathevan JJ, Tallon L, Althoff R, Arbogast TS: Sequencing Bacillus
anthracis typing phages Gramma and Cherry reveals a common
ancestry. J Bacteriol 2006, 188(9):3402–3408.
29. Klumpp J, Calendar R, Loessner MJ: Complete Nucleotide Sequence and
Molecular Characterization of Bacillus Phage TP21 and its Relatedness to
Other Phages with the Same Name. Viruses-Basel 2010, 2(4):961–971.
30. Cheng Q, Fischetti VA: Mutagenesis of a bacteriophage lytic enzyme
PlyGBS significantly increases its antibacterial activity against group B
streptococci. Appl Microbiol Biot 2007, 74(6):1284–1291.
31. Briers Y, Volckaert G, Cornelissen A, Lagaert S, Michiels CW, Hertveldt K,
Lavigne R: Muralytic activity and modular structure of the endolysins of
Pseudomonas aeruginosa bacteriophages phi KZ and EL. Mol Microbiol
2007, 65(5):1334–1344.
32. Kikkawa H, Fujinami Y, Suzuki SI, Yasuda J: Identification of the amino acid
residues critical for specific binding of the bacteriolytic enzyme of
gamma-phage, PlyG, to Bacillus anthracis. Bioch Bioph Res Co 2007,
363(3):531–535.
33. Bustamante N, Campillo NE, Garcia E, Gallego C, Pera B, Diakun GP, Saiz JL,
Garcia P, Diaz JF, Menendez M: Cpl-7, a Lysozyme Encoded by a
Pneumococcal Bacteriophage with a Novel Cell Wall-binding Motif.
J Biol Chem 2010, 285(43):33184–33196.
34. Heyndrickx M, Scheldeman P: Bacilli associated with spoilage in dairy
products and other food. In Applications and Systematics of Bacillus and
Relatives. 2002:64–82.
35. Granum PE, Lund T: Bacillus cereus and its food poisoning toxins.
FEMS Microbiol Lett 1997, 157(2):223–228.
36. Schmelcher M, Waldherr F, Loessner MJ: Listeria bacteriophage
peptidoglycan hydrolases feature high thermoresistance and reveal
increased activity after divalent metal cation substitution. Appl Microbiol
Biot 2012, 93(2):633–643.
37. Adang MJ, Staver MJ, Rocheleau TA, Leighton J, Barker RF, Thompson DV:
Characterized Full-Length and Truncated Plasmid Clones of the Crystal
Protein of Bacillus-Thuringiensis Subsp Kurstaki Hd-73 and Their Toxicity
to Manduca-Sexta. Gene 1985, 36(3):289–300.
38. Srogl M: Some Factors Influencing Frequency of Transformation of
Bacillus Subtilis 168. Folia Microbiol 1965, 10(3):202.
39. Altschul SF, Madden TL, Schaffer AA, Zhang JH, Zhang Z, Miller W, Lipman
DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 1997, 25(17):3389–3402.
40. Thompson JD, Higgins DG, Gibson TJ: Clustal-W:Improving the Sensitivity
of Progressive Multiple Sequence Alignment through Sequence
Weighting, Position-Specific Gap Penalties and Weight Matrix Choice.
Nucleic Acids Res 1994, 22(22):4673–4680.
41. Bateman A, Coin L, Durbin R, Finn RD, Hollich V, Griffiths-Jones S, Khanna A,
Marshall M, Moxon S, Sonnhammer ELL: The Pfam protein families
database. Nucleic Acids Res 2004, 32:D138–D141.
42. Marchler-Bauer A, Lu SN, Anderson JB, Chitsaz F, Derbyshire MK,
DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales RC, et al: CDD: a
Conserved Domain Database for the functional annotation of proteins.
Nucleic Acids Res 2011, 39:D225–D229.
43. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. A laboratory manual.
3rd edition. Cold Spring Harbor: Cold spring Harbor laboratory Press; 2001.
44. Santos MA: An improved method for the small-scale preparation of
bacteriophage DNA baded on phage precipitation by Zinz-Chloride.
Nucleic Acids Res 1991, 19(19):5442–5442.
45. Schleicher E, Wieland OH: Evaluation of Bradford Method for Protein
Determination in Body-Fluids. J Clin Chem Clin Biochem 1978,
16(9):533–534.
46. Gerova M, Halgasova N, Ugorcakova J, Bukovska G: Endolysin of
bacteriophage BFK20: evidence of a catalytic and a cell wall binding
domain. FEMS Microbiol Lett 2011, 321(2):83–91.
doi:10.1186/1471-2180-12-297
Cite this article as: Yuan et al.: Characteristics of a broad lytic spectrum
endolysin from phage BtCS33 of Bacillus thuringiensis. BMC Microbiology
2012 12:297.
